| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 8,940,401 | 9,621,316 | 9,918,690 | | Cost of Revenue | 6,326,459 | 8,695,076 | 8,645,254 | | | Gross Profit | 2,613,942 | 926,240 | 1,273,436 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,394,274 | 437,323 | 435,876 | | Non Recurring | 1,029,503 | 798,440 | 17,942 | | Others | 264,291 | 255,603 | 274,184 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,074,126) | (565,126) | 545,434 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,571 | 2,169 | (1,718) | | Earnings Before Interest And Taxes | (1,065,555) | (562,957) | 543,716 | | Interest Expense | 77,907 | 88,760 | 87,760 | | Income Before Tax | (1,143,462) | (651,717) | 455,956 | | Income Tax Expense | (169,070) | (13,336) | 179,324 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (974,392) | (638,381) | 276,632 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (974,392) | (638,381) | 276,632 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($974,392) | ($638,381) | $276,632 |
|
0.18% Nasdaq 
0.42%
Income Statement
